Skip to main content
Erschienen in: Urolithiasis 5/2013

01.10.2013 | Original Paper

The presence and distribution of alpha adrenergic receptors in human renal pelvis and calyces

verfasst von: Osman Raif Karabacak, Demet Yilmazer, Ufuk Ozturk, Nevzat Can Sener, Hakan Saltas, Yurdum Karabacak, Murat Alper

Erschienen in: Urolithiasis | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

In this study, we aimed to demonstrate the presence of Alpha (α) 1 receptors and subtypes in human pelvis and calyces, because an agent to facilitate kidney stone movement and help decrease pain may be an α 1 adrenergic blocker, as used in ureteral stones. Twenty patients who applied to our clinic for renal cell carcinoma were enrolled to the study. All patients underwent radical nephrectomy. After the specimens were removed, excisional biopsies were performed on healthy pelvises and calyces. Mean α-receptor stain rates in renal pelvis were 2.65 ± 0.74, 1.35 ± 0.81 and 2.9 ± 0.30 for α 1A, 1B and 1D, respectively. For calyces, the rates are 2.40 ± 0.82, 1.50 ± 0.76 and 2.75 ± 0.44 for α 1A, 1B and 1D, respectively (Fig. 1). When the staining patterns were compared, α 1A and 1D were expressed more in both pelvis and calyces than α 1B (p < 0.05). After the demonstration of α-adrenergic receptors in pelvis and calyces of human kidney, it may be helpful in coming up with new alternative treatments for patients suffering from kidney stones.
Literatur
1.
Zurück zum Zitat Walden PD, Gerardi C, Lepor H (1999) Localization and expression of the Alpha1A-1, Alpha1B and Alpha1D-adrenoceptors in hyperplastic and non-hyperplastic human prostate. J Urol 161:635–640PubMedCrossRef Walden PD, Gerardi C, Lepor H (1999) Localization and expression of the Alpha1A-1, Alpha1B and Alpha1D-adrenoceptors in hyperplastic and non-hyperplastic human prostate. J Urol 161:635–640PubMedCrossRef
2.
Zurück zum Zitat Porpiglia F, Vaccino D, Bilia M et al (2006) Corticosteroids and tamsulosin in the medical expulsive therapy for symptomatic distal ureter stones; single drug or association. Eur Urol 50:339–344PubMedCrossRef Porpiglia F, Vaccino D, Bilia M et al (2006) Corticosteroids and tamsulosin in the medical expulsive therapy for symptomatic distal ureter stones; single drug or association. Eur Urol 50:339–344PubMedCrossRef
3.
Zurück zum Zitat Lee KS, Deok HH, Lee YS, Choo MS, Yoo TK, Park HJ, Yoon H, Jeong H, Lee SJ, Kim H, Park WH (2010) Efficacy and safety of tamsulosin for the treatment of non-neurogenic voiding dysfunction in females: a 8 week prospective study. J Korean Med Sci 25:117–122PubMedCrossRef Lee KS, Deok HH, Lee YS, Choo MS, Yoo TK, Park HJ, Yoon H, Jeong H, Lee SJ, Kim H, Park WH (2010) Efficacy and safety of tamsulosin for the treatment of non-neurogenic voiding dysfunction in females: a 8 week prospective study. J Korean Med Sci 25:117–122PubMedCrossRef
4.
Zurück zum Zitat Lipkin M, Shah O (2006) The use of alpha-blockers for the treatment of nephrolithiasis. Rev Urol 4:S35–S42 Lipkin M, Shah O (2006) The use of alpha-blockers for the treatment of nephrolithiasis. Rev Urol 4:S35–S42
5.
Zurück zum Zitat Seitz C, Liatsikos E, Porpiglia F et al (2009) Medical therapy to facilitate the passage of stones: what is the evidence? Eur Urol 56:455–471PubMedCrossRef Seitz C, Liatsikos E, Porpiglia F et al (2009) Medical therapy to facilitate the passage of stones: what is the evidence? Eur Urol 56:455–471PubMedCrossRef
6.
Zurück zum Zitat Gravina GL, Costa AM, Ronchi P, Galatioto GP, Angelucci A, Castellani D, Narcisi F, Vicentini C (2005) Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones. Urology 66:24–28PubMedCrossRef Gravina GL, Costa AM, Ronchi P, Galatioto GP, Angelucci A, Castellani D, Narcisi F, Vicentini C (2005) Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones. Urology 66:24–28PubMedCrossRef
7.
Zurück zum Zitat Itoh Y, Kojima Y, Yasui T et al (2007) Examination of Alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol 14:749–753PubMedCrossRef Itoh Y, Kojima Y, Yasui T et al (2007) Examination of Alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol 14:749–753PubMedCrossRef
8.
Zurück zum Zitat Park HK, Choi EY, Jeong BC, Kim HH, Kim BK (2007) Localizations and expressions of alpha-1A, alpha-1B and alpha-1D adrenoceptors in humanureter. Urol Res 35:325–329PubMedCrossRef Park HK, Choi EY, Jeong BC, Kim HH, Kim BK (2007) Localizations and expressions of alpha-1A, alpha-1B and alpha-1D adrenoceptors in humanureter. Urol Res 35:325–329PubMedCrossRef
9.
Zurück zum Zitat Kunisawa Y, Kawabe K, Niijima T, Honda K, Takenaka T (1985) A pharmacological study of Alpha adrenergic recepto rsubtypes in smooth muscle of human urinary bladder base and prostatic urethra. J Urol 134:396–398PubMed Kunisawa Y, Kawabe K, Niijima T, Honda K, Takenaka T (1985) A pharmacological study of Alpha adrenergic recepto rsubtypes in smooth muscle of human urinary bladder base and prostatic urethra. J Urol 134:396–398PubMed
10.
Zurück zum Zitat Turk C, Knoll T, Petrik A, Sarica K, Straub M, Seitz C. Guidelines on Urolithiasis 2012, In: EAU Guidelines, Uroweb 2012 Turk C, Knoll T, Petrik A, Sarica K, Straub M, Seitz C. Guidelines on Urolithiasis 2012, In: EAU Guidelines, Uroweb 2012
11.
Zurück zum Zitat Ye Z, Yang H, Li H, Zhang X, Deng Y, Zeng G, Chen L, Cheng Y, Yang J, Mi Q, Zhang Y, Chen Z, Guo H, He W, Chen Z (2011) A multicentre, prospective, randomized trial: comparative efficacy of tamsulosin and nifedipine in medical expulsive therapy for distal ureteric stones with renal colic. BJU Int 108:276–279PubMedCrossRef Ye Z, Yang H, Li H, Zhang X, Deng Y, Zeng G, Chen L, Cheng Y, Yang J, Mi Q, Zhang Y, Chen Z, Guo H, He W, Chen Z (2011) A multicentre, prospective, randomized trial: comparative efficacy of tamsulosin and nifedipine in medical expulsive therapy for distal ureteric stones with renal colic. BJU Int 108:276–279PubMedCrossRef
12.
Zurück zum Zitat Falahatkar S, Khosropanah I, Vajary AD, Bateni ZH, Khosropanah D, Allahkhah A (2011) Is there a role for tamsulosin after shock wave lithotripsy in the treatment of renal and ureteral calculi? J Endourol 25:495–498PubMedCrossRef Falahatkar S, Khosropanah I, Vajary AD, Bateni ZH, Khosropanah D, Allahkhah A (2011) Is there a role for tamsulosin after shock wave lithotripsy in the treatment of renal and ureteral calculi? J Endourol 25:495–498PubMedCrossRef
13.
Zurück zum Zitat Bhagat SK, Chacko NK, Kekre NS, Gopalakrishnan G, Antonisamy B, Devasia A (2007) Is there a role for tamsulosin in shock wave lithotripsy for renal and ureteral calculi? J Urol 177:2185–2188PubMedCrossRef Bhagat SK, Chacko NK, Kekre NS, Gopalakrishnan G, Antonisamy B, Devasia A (2007) Is there a role for tamsulosin in shock wave lithotripsy for renal and ureteral calculi? J Urol 177:2185–2188PubMedCrossRef
14.
Zurück zum Zitat Zaytoun OM, Yakoubi R, Zahran AR, Fouda K, Marzouk E, Gaafar S, Fareed K (2012) Tamsulosin and doxazosin as adjunctive therapy following shock-wave lithotripsy of renal calculi: randomized controlled trial. Urol Res 40:327–332PubMedCrossRef Zaytoun OM, Yakoubi R, Zahran AR, Fouda K, Marzouk E, Gaafar S, Fareed K (2012) Tamsulosin and doxazosin as adjunctive therapy following shock-wave lithotripsy of renal calculi: randomized controlled trial. Urol Res 40:327–332PubMedCrossRef
15.
Zurück zum Zitat Rajpathy J, Aswathaman K, Sinha M, Subramani S, Gopalakrishnan G, Kekre NS (2008) An in vitro study on human ureteric smooth muscle with the alpha1-adrenoceptor subtype blocker, tamsulosin. BJU Int 102:1743–1745PubMedCrossRef Rajpathy J, Aswathaman K, Sinha M, Subramani S, Gopalakrishnan G, Kekre NS (2008) An in vitro study on human ureteric smooth muscle with the alpha1-adrenoceptor subtype blocker, tamsulosin. BJU Int 102:1743–1745PubMedCrossRef
16.
Zurück zum Zitat Iqbal J, Tonta MA, Mitsui R, Li Q, Kett M, Li J, Parkington HC, Hashitani H, Lang RJ (2012) Potassium and ANO1/TMEM16A chloride channel profiles distinguish atypical and typical smooth muscle cells from interstitial cells in the mouse renal pelvis. Br J Pharmacol 165:2389–2408PubMedCrossRef Iqbal J, Tonta MA, Mitsui R, Li Q, Kett M, Li J, Parkington HC, Hashitani H, Lang RJ (2012) Potassium and ANO1/TMEM16A chloride channel profiles distinguish atypical and typical smooth muscle cells from interstitial cells in the mouse renal pelvis. Br J Pharmacol 165:2389–2408PubMedCrossRef
17.
Zurück zum Zitat Sasaki S, Tomiyama Y, Kobayashi S, Kojima Y, Kubota Y, Kohri K (2011) Characterization of α1-adrenoceptor subtypes mediating contraction in human isolated ureters. Urology 77:762.e13-7 Sasaki S, Tomiyama Y, Kobayashi S, Kojima Y, Kubota Y, Kohri K (2011) Characterization of α1-adrenoceptor subtypes mediating contraction in human isolated ureters. Urology 77:762.e13-7
18.
Zurück zum Zitat Kobayashi S, Tomiyama Y, Maruyama K, Hoyano Y, Yamazaki Y, Kusama H (2009) Effect of four different alpha(1)-adrenoreceptor antagonists on alpha-adrenoreceptor agonist- induced contractions in isolated mouse and hamster ureters. J Smooth Muscle Res 45:187–195PubMedCrossRef Kobayashi S, Tomiyama Y, Maruyama K, Hoyano Y, Yamazaki Y, Kusama H (2009) Effect of four different alpha(1)-adrenoreceptor antagonists on alpha-adrenoreceptor agonist- induced contractions in isolated mouse and hamster ureters. J Smooth Muscle Res 45:187–195PubMedCrossRef
Metadaten
Titel
The presence and distribution of alpha adrenergic receptors in human renal pelvis and calyces
verfasst von
Osman Raif Karabacak
Demet Yilmazer
Ufuk Ozturk
Nevzat Can Sener
Hakan Saltas
Yurdum Karabacak
Murat Alper
Publikationsdatum
01.10.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Urolithiasis / Ausgabe 5/2013
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-013-0592-5

Weitere Artikel der Ausgabe 5/2013

Urolithiasis 5/2013 Zur Ausgabe

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.